The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery

References

• Kumar TR, Soppimath K, Nachaegari SK. (2006). Novel delivery technologies for protein and peptide therapeutics. Curr Pharm Biotechnol, 7:261–76.
   PubMed Web of Science ®Google Scholar
• Harsch IA. (2005). Inhaled insulins their potential in the treatment of diabetes mellitus. Treat Endocrinol, 4(3):131–8.
   PubMedGoogle Scholar
• Odegard PS, Capoccia KL. (2005). Inhaled insulin: Exubera. Ann Pharmacother, 39:843–53.
   PubMed Web of Science ®Google Scholar
• Skyler JS, Hollander PA, Jovanovic L. (2008). Safety and efficacy of inhaled human insulin (Exubera®) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial. Diabetes Res Clin Pract, 82(2):238–46.
   PubMed Web of Science ®Google Scholar
• Yamamoto A, Iseki T, Ochi-Sugiyama M, Okada N, Fujita T, Muranishi S. (2001). Absorption of water-soluble compounds with different molecular weights and [Asu1,7]-eel calcitonin from various mucosal administration sites. J Control Release, 76:363–74.
   PubMed Web of Science ®Google Scholar
• Todo H, Okamoto H, Iida K, Danjo K. (2001). Effect of additives on insulin absorption from intratracheally administered dry powders in rats. Int J Pharm, 220:101–110.
   PubMed Web of Science ®Google Scholar
• Florea BI, Thanou M, Junginger HE, Borchard G. (2006). Enhancement of bronchial octreotide absorption by chitosan and N-trimethyl chitosan shows linear in vitro/in vivo correlation. J Control Release, 110:353–61.
   PubMed Web of Science ®Google Scholar
• Hussain A, Arnold JJ, Khan MA, Ahsan F. (2004). Absorption enhancers in pulmonary protein delivery. J Control Release, 94:15–24.
   PubMed Web of Science ®Google Scholar
• Yamada K, Odomi M, Okada N, Fujita T, Yamamoto A. (2005). Chitosan oligomers as potential and safe absorption enhancers for improving the pulmonary absorption of interferon-α in rats. J Pharm Sci, 94:2432–40.
   PubMed Web of Science ®Google Scholar
• Bhavane R, Karathanasis E, Annapragada AV. (2003). Agglomerated vesicle technology: A new class of particles for controlled and modulated pulmonary drug delivery. J Control Release, 93:15–28.
   PubMed Web of Science ®Google Scholar
• Surendrakumar K, Martyn GP, Blair JA. (2003). Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs. J Control Release, 91:385–94.
   PubMed Web of Science ®Google Scholar
• Hallman M, Glumoff V, Ramet M. (2001). Surfactant in respiratory distress syndrome and lung injury. Comp Biochem Physiol A Mol Integr Physiol, 129:287–94.
   PubMed Web of Science ®Google Scholar
• Seeger W, Gunther A, Walmrath HD, Grimminger F, Lasch HG. (1993). Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects. Clin Investig, 71:177–90.
   PubMedGoogle Scholar
• Veldhuizen R, Nag K, Orgeig S, Possmayer F. (1998). The role of lipids in pulmonary surfactant. Biochim Biophys Acta, 1408:90–108.
   PubMed Web of Science ®Google Scholar
• Haagsman HP, Diemel RV. (2001). Surfactant-associated proteins: Functions and structural variation. Comp Biochem Physiol A Mol Integr Physiol, 129:91–108.
   PubMed Web of Science ®Google Scholar
• Crouch E, Wright JR. (2001). Surfactant proteins a and d and pulmonary host defense. Annu Rev Physiol, 63:521–54.
   PubMed Web of Science ®Google Scholar
• Weaver TE, Conkright JJ. (2001). Function of surfactant proteins B and C. Annu Rev Physiol, 63:555–78.
   PubMed Web of Science ®Google Scholar
• Serrano AG, Pérez-Gil J. (2006). Protein–lipid interactions and surface activity in the pulmonary surfactant system. Chem Phys Lipids, 141:105–18.
   PubMed Web of Science ®Google Scholar
• Korimilli A, Gonzales LW, Guttentag SH. (2000). Intracellular localization of processing events in human surfactant protein B biosynthesis. J Biol Chem, 275:8672–9.
   Google Scholar
• Plasencia I, Keough KM, Perez-Gil J. (2005). Interaction of the N-terminal segment of pulmonary surfactant protein SP-C with interfacial phospholipid films. Biochim Biophys Acta, 1713:118–28.
   PubMed Web of Science ®Google Scholar
• Vermehren C, Frokjaer S, Aurstad T, Hansen J. (2006). Lung surfactant as a drug delivery system. Int J Pharm, 307:89–92.
   PubMedGoogle Scholar
• Mitra R, Pezron I, Li Y, Mitra A. (2001). Enhanced pulmonary delivery of insulin by lung lavage fluid and phospholipids. Int J Pharma, 217:25–31.
   PubMed Web of Science ®Google Scholar
• Folch J, Lees M, Stanley GHS. (1957). A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem, 226:497–509.
   PubMed Web of Science ®Google Scholar
• Poyner EA, Alpar HO, Almeida AJ, Gamble MD, Brown MRW. (1995). A comparative study on the pulmonary delivery of tobramycin encapsulated into liposomes and PLA microspheres following intravenous and endotracheal delivery. J Control Release, 35:41–8.
   Web of Science ®Google Scholar
• Morishita M, Goto T, Nakamura K, Lowman AM, Takayama K, Peppas NA. (2006). Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in types 1 and 2 diabetic rats. J Control Release, 110:587–94.
   PubMed Web of Science ®Google Scholar
• Schram V, Hall SB. (2001). Thermodynamic effects of the hydrophobic surfactant proteins on the early adsorption of pulmonary surfactant. Biophys J, 81:1536–46.
   PubMed Web of Science ®Google Scholar
• Schram V, Hall SB. (2004). SP-B and SP-C alter diffusion in bilayers of pulmonary surfactant. Biophys J, 86:3734–43.
   PubMed Web of Science ®Google Scholar
• Li HY, Neill H, Innocent R, Seville P, Williamson I, Birchall JC. (2003). Enhanced dispersibility and deposition of spray-dried powders for pulmonary gene therapy. J Drug Target, 11(7):425–32.
   PubMed Web of Science ®Google Scholar
• Najafabadi AR, Gilani K, Barghi M, Rafiee-Tehrani M. (2004). The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with L-Leucine. Int J Pharm, 285(1–2):97–108.
   PubMed Web of Science ®Google Scholar
• Gervelas C, Serandour A-L, Geiger S. (2007). Direct lung delivery of a dry powder formulation of DTPA with improved aerosolization properties: Effect on lung and systemic decorporation of plutonium. J Control Release, 118:78–86.
   PubMed Web of Science ®Google Scholar
• Bosquillon C, Préat V, Vanbever R. (2004). Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats. J Control Release, 96(2):233–44.
   PubMed Web of Science ®Google Scholar
• Codrons V, Vanderbist F, Ucakar B, Préat V, Vanbever R. (2004). Impact of formulation and methods of pulmonary delivery on absorption of parathyroid hormone (1–34) from rat lungs. J Pharm Sci, 93(5):1241–52.
   PubMed Web of Science ®Google Scholar
• Bosquillon C, Lombry C, Préat V, Vanbever R. (2001). Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. J Control Release, 70:329–39.
   PubMed Web of Science ®Google Scholar
• Codrons V, Vanderbist F, Ucakar B, Préat V, Vanbever R. (2004). Impact of formulation and methods of pulmonary delivery on absorption of parathyroid hormone (1–34) from rat lungs. J Pharm Sci, 93:1241–52.
   PubMed Web of Science ®Google Scholar
• Roelofsen B, Kuypers FA, Op-den-Kamp JA, Van Deenen LL. (1989). Influence of phosphatidylcholine molecular species composition on stability of the erythrocyte membrane. Biochem Soc Trans, 17:284–6.
   PubMed Web of Science ®Google Scholar
• Lindmark T, Kimura Y, Artursson P. (1998). Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. J Pharmacol Exp Ther, 284:362–9.
   PubMed Web of Science ®Google Scholar
• Bosquillon C, Préat V, Vanbever R. (2004). Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats. J Control Release, 96:233–44.
   PubMed Web of Science ®Google Scholar
• Schram V, Hall SB. (2001). Thermodynamic effects of the hydrophobic surfactant proteins on the early adsorption of pulmonary surfactant. Biophys J, 81:1536–46.
   PubMed Web of Science ®Google Scholar
• Schram V, Hall SB. (2004). SP-B and SP-C alter diffusion in bilayers of pulmonary surfactant. Biophys J, 86:3734–43.
   PubMed Web of Science ®Google Scholar